Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Taxotere (docetaxel)

Audience: Wholesalers, hospital pharmacists, and oncology healthcare professionals

Aventis Pharmaceuticals has initiated a voluntary recall of Taxotere® (docetaxel) for Injection Concentrate 20-mg active and diluent vials. The lot numbers for this recall are: 0P273 (active) which was packaged together with diluent vials with the following lot numbers: 0T446 (diluent) or 0T449 (diluent). It has been determined that the Taxotere 20mg vial containing the active ingredient may have inadvertently been labeled as a “diluent” vial. Aventis has received one product complaint related to this mislabeling.

[March 28, 2001 - Letter to Healthcare Professionals - Aventis Pharmaceuticals]
[March 28, 2001 - Letter to Wholesalers - Aventis Pharmaceuticals]

-
-